We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Assurant
AIZ
$14B
| $14.9M | 0.15% |
122,853
-2,993
| -2% | -$344K |
|
152
EOG Resources
EOG
$74.7B
| $14.6M | 0.15% |
405,657
-35,340
| -8% | -$1.59M |
|
153
BioMarin Pharmaceuticals
BMRN
$11.9B
| $14.6M | 0.15% |
+191,373
| New | +$19.4M |
|
154
iShares Russell 2000 Value ETF
IWN
$14.5B
| $14.5M | 0.15% |
146,160
| – | – |
|
155
Raymond James Financial
RJF
$33.7B
| $14.5M | 0.15% |
299,150
-48,814
| -14% | -$2.36M |
|
|
ICPT
156
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $14.4M | 0.15% |
347,246
+297,789
| +602% | +$13.7M |
|
157
Element Solutions
ESI
$8.78B
| $14.3M | 0.15% |
1,359,812
+52,198
| +4% | +$572K |
|
158
Allison Transmission
ALSN
$10.1B
| $14.3M | 0.15% |
406,629
-75,431
| -16% | -$2.73M |
|
159
Adient
ADNT
$1.68B
| $14.1M | 0.15% |
813,824
+134,818
| +20% | +$2.35M |
|
160
NETSCOUT
NTCT
$2.9B
| $14M | 0.15% |
642,372
-25,415
| -4% | -$614K |
|
161
Coca-Cola Consolidated
COKE
$13B
| $13.8M | 0.14% |
575,220
+30,570
| +6% | +$766K |
|
|
INFN
162
DELISTED
Infinera Corporation Common Stock
INFN
| $13.8M | 0.14% |
2,246,377
-43,251
| -2% | -$303K |
|
163
Quanta Services
PWR
$88.7B
| $13.8M | 0.14% |
261,541
-157,292
| -38% | -$7.32M |
|
|
Y
164
DELISTED
Alleghany Corp
Y
| $13.8M | 0.14% |
26,443
-1,838
| -6% | -$966K |
|
165
NCR Voyix
VYX
$1.18B
| $13.6M | 0.14% |
999,438
+133,993
| +15% | +$1.59M |
|
166
Seagate
STX
$169B
| $13.5M | 0.14% |
274,851
+21,716
| +9% | +$1.02M |
|
167
Aecom
ACM
$9.64B
| $13.5M | 0.14% |
323,419
+91,311
| +39% | +$3.48M |
|
168
GoPro
GPRO
$122M
| $13.5M | 0.14% |
2,986,477
-117,682
| -4% | -$553K |
|
|
ARCH
169
DELISTED
Arch Resources, Inc.
ARCH
| $13.3M | 0.14% |
313,470
-24,758
| -7% | -$879K |
|
170
NETGEAR
NTGR
$673M
| $13.2M | 0.14% |
428,780
-21,222
| -5% | -$644K |
|
171
AbbVie
ABBV
$470B
| $13M | 0.14% |
148,694
-80,409
| -35% | -$7.57M |
|
172
Xerox
XRX
$357M
| $12.9M | 0.13% |
688,586
-16,512
| -2% | -$289K |
|
173
F5
FFIV
$23.2B
| $12.8M | 0.13% |
104,462
+5,327
| +5% | +$716K |
|
174
James River Group Holdings
JRVR
$221M
| $12.8M | 0.13% |
287,501
-19,136
| -6% | -$892K |
|
175
Merit Medical Systems
MMSI
$4.68B
| $12.7M | 0.13% |
292,973
+96,331
| +49% | +$4.35M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.